VTVT Message Board Post 9880594 | vTv Therapeutics Inc.
home / stock / vtvt / vtvt message board
urosporenta
(investorshub)
Posted on: Jun/01/2022 20:52:45
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169028397
What a good talk ....when is offering
News, Short Squeeze, Breakout and More Instantly...
-
2024-06-26 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed in over ...
-
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING PR Newswire WESTON, Fla. , May 28, 2024 /PRNewswire/ -- Cantex Pharmaceuticals , Inc., a clinical stage pharmaceutical company focused on developi...